Article Type
Changed
Display Headline
Do Bisphosphonates Reduce Cancer Risks?

SAN ANTONIO Dr. William J. Gradishar, associate editor of The Oncology Report, discusses the conflicting results from multiple clinical trials over the last decade and whether bisphosphonates reduce cancer recurrence and metastatic risk.

Author and Disclosure Information

Publications
Topics
Legacy Keywords
clinical cancer trials, bisphosphonates cancer, cancer recurrence, metastatic risk, Dr. William J. Gradishar
Author and Disclosure Information

Author and Disclosure Information

SAN ANTONIO Dr. William J. Gradishar, associate editor of The Oncology Report, discusses the conflicting results from multiple clinical trials over the last decade and whether bisphosphonates reduce cancer recurrence and metastatic risk.

SAN ANTONIO Dr. William J. Gradishar, associate editor of The Oncology Report, discusses the conflicting results from multiple clinical trials over the last decade and whether bisphosphonates reduce cancer recurrence and metastatic risk.

Publications
Publications
Topics
Article Type
Display Headline
Do Bisphosphonates Reduce Cancer Risks?
Display Headline
Do Bisphosphonates Reduce Cancer Risks?
Legacy Keywords
clinical cancer trials, bisphosphonates cancer, cancer recurrence, metastatic risk, Dr. William J. Gradishar
Legacy Keywords
clinical cancer trials, bisphosphonates cancer, cancer recurrence, metastatic risk, Dr. William J. Gradishar
Article Source

PURLs Copyright

Inside the Article